Latest Insider Transactions at Chemours CO (CC)
This section provides a real-time view of insider transactions for Chemours CO (CC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Chemours Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Chemours Co's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 01
2021
|
Denise Dignam President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
333
-2.66%
|
$7,992
$24.01 P/Share
|
Mar 01
2021
|
Alvenia Scarborough SVP Corp Communications & CBO |
BUY
Grant, award, or other acquisition
|
Direct |
1,041
+7.83%
|
-
|
Mar 01
2021
|
Alvenia Scarborough SVP Corp Communications & CBO |
SELL
Payment of exercise price or tax liability
|
Direct |
319
-2.77%
|
$7,656
$24.01 P/Share
|
Feb 12
2021
|
Edwin C Sparks President, Titan Tech Chem Sol |
BUY
Payment of exercise price or tax liability
|
Direct |
247
+0.29%
|
$6,422
$26.14 P/Share
|
Feb 12
2021
|
Edwin C Sparks President, Titan Tech Chem Sol |
BUY
Grant, award, or other acquisition
|
Direct |
657
+0.77%
|
-
|
Feb 12
2021
|
Susan M. Kelliher SVP, People and Health Service |
SELL
Payment of exercise price or tax liability
|
Direct |
449
-1.29%
|
$11,674
$26.14 P/Share
|
Feb 12
2021
|
Susan M. Kelliher SVP, People and Health Service |
BUY
Grant, award, or other acquisition
|
Direct |
1,195
+3.32%
|
-
|
Feb 12
2021
|
Sameer Ralhan SVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
224
-0.08%
|
$5,824
$26.14 P/Share
|
Feb 12
2021
|
Sameer Ralhan SVP, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
597
+0.2%
|
-
|
Feb 12
2021
|
E Bryan Snell President, Titanium Tech |
SELL
Payment of exercise price or tax liability
|
Direct |
807
-0.56%
|
$20,982
$26.14 P/Share
|
Feb 12
2021
|
E Bryan Snell President, Titanium Tech |
BUY
Grant, award, or other acquisition
|
Direct |
2,151
+1.47%
|
-
|
Feb 12
2021
|
Mark P Vergnano Director |
SELL
Payment of exercise price or tax liability
|
Direct |
4,325
-1.69%
|
$112,450
$26.14 P/Share
|
Feb 12
2021
|
Mark P Vergnano Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,142
+4.89%
|
-
|
Feb 12
2021
|
Mark Newman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,188
-0.87%
|
$30,888
$26.14 P/Share
|
Feb 12
2021
|
Mark Newman President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
2,868
+2.06%
|
-
|
Feb 12
2021
|
David C Shelton SVP, GC & Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
762
-1.92%
|
$19,812
$26.14 P/Share
|
Feb 12
2021
|
David C Shelton SVP, GC & Corp. Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
2,031
+4.87%
|
-
|
Dec 18
2020
|
Mark P Vergnano Director |
SELL
Open market or private sale
|
Direct |
153,392
-38.76%
|
$4,141,584
$27.28 P/Share
|
Dec 18
2020
|
Mark P Vergnano Director |
BUY
Exercise of conversion of derivative security
|
Direct |
153,392
+27.93%
|
$2,300,880
$15.49 P/Share
|
Dec 01
2020
|
Susan M. Kelliher SVP, People and Health Service |
BUY
Grant, award, or other acquisition
|
Direct |
19,755
+37.01%
|
-
|
Dec 01
2020
|
Sameer Ralhan SVP, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
39,510
+11.9%
|
-
|
Dec 01
2020
|
Edwin C Sparks President, Titan Tech Chem Sol |
BUY
Grant, award, or other acquisition
|
Direct |
39,510
+32.14%
|
-
|
Nov 10
2020
|
E Bryan Snell President, Titanium Tech |
SELL
Open market or private sale
|
Direct |
28,341
-16.65%
|
$623,502
$22.29 P/Share
|
Nov 10
2020
|
E Bryan Snell President, Titanium Tech |
BUY
Exercise of conversion of derivative security
|
Direct |
28,341
+14.27%
|
$425,115
$15.49 P/Share
|